You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ)擬推不超1728.1825萬股限制性股票激勵計劃
格隆匯 12-14 21:22

格隆匯 12 月 14日丨重藥控股(000950.SZ)披露2020年限制性股票激勵計劃(草案),該激勵計劃授予的限制性股票總數量不超過1728.1825萬股,即不超過該激勵計劃提交股東大會審議前公司股本總額的1%。該激勵計劃中任何一名激勵對象所獲授限制性股票數量未超過公司股本總額的1%。

限制性股票的來源為公司向激勵對象定向發行的重藥控股股份有限公司A股普通股,該激勵計劃限制性股票的授予價格為2.76元/股。該激勵計劃的激勵對象不超過270人,包括:公司董事、高級管理人員、經公司董事會認定的對公司經營業績和未來發展有直接影響的核心業務、技術和管理骨幹(不包括重藥控股獨立董事、監事以及外部董事)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account